{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-037885","form_type":"8-K","ticker":"CUE","cik":"0001645460","company_name":"Cue Biopharma, Inc.","filed_at":"2025-03-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.290165+00:00","generated_at":"2026-05-24T22:35:47.164202+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Cue Biopharma appoints Pasha Sarraf to board of directors","bullets":["Pasha Sarraf appointed to board on March 10, 2025.","Granted option to purchase 48,800 shares vesting over three years.","Compensation per Company's Director Compensation Policy.","Entered standard indemnification agreement for director service.","No arrangements or transactions between Sarraf and Company."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-037885","json":"https://secwatch.observer/filing/0000950170-25-037885.json","markdown":"https://secwatch.observer/filing/0000950170-25-037885.md","text":"https://secwatch.observer/filing/0000950170-25-037885.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1645460/000095017025037885/0000950170-25-037885-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1645460/000095017025037885/cue-20250310.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T22:35:47.164202+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"09bcb29e9c","claim":"Pasha Sarraf was appointed as member of the board of directors at Cue Biopharma, Inc..","evidence_excerpt":"On March 10, 2025, Pasha Sarraf was appointed to the board of directors (the “Board”) of Cue Biopharma, Inc. (the “Company”), following the recommendation of the Corporate Governance and Nominating Committee of the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1645460/000095017025037885/0000950170-25-037885-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"member of the board of directors"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}